Target-197R-Meclizine HCl Tablets
- Manufacturer
- TARGET CORPORATION | TIME CAP LABORATORIES, INC. | TIME CAP LABORATORIES INC
- Effective date
- 2025-09-04
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 01:42:13
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
Active ingredient (in each tablet)
Meclizine HCl 25 mg
OTC - PURPOSE SECTION
Purpose
Antiemetic
INDICATIONS & USAGE SECTION
Uses
for prevention and treatment of these symptoms associated with motion sickness:
- nausea
- vomiting
- dizziness
WARNINGS SECTION
Warnings
OTC - DO NOT USE SECTION
Do not give to children under 12 years of age unless directed by a doctor
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have
- a breathing problem such as emphysema or chronic bronchitis
- glaucoma
- trouble urinating due to an enlarged prostate gland
OTC - ASK DOCTOR/PHARMACIST SECTION
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers
OTC - WHEN USING SECTION
When using this product
- drowsiness may occur
- avoid alcoholic drinks
- alcohol, sedatives, and tranquilizers may increase drowsiness
- use caution when driving a motor vehicle or operating machinery
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
DOSAGE & ADMINISTRATION SECTION
Directions
- take first dose ½ to one hour before starting activity
- adults and children 12 years and over: 1 to 2 tablets once daily, or as directed by a doctor
OTHER SAFETY INFORMATION
Other information
- store at 25℃ (77℉) – excursions permitted between 15°-30℃ (59°-86℉)
INACTIVE INGREDIENT SECTION
Inactive ingredients anhydrous lactose, colloidal silicon dioxide, corn starch, D&C yellow #10 aluminum lake, magnesium stearate, microcrystalline cellulose, sodium starch glycolate
OTC - QUESTIONS SECTION
Questions or comments? Call 1-800-910-6874
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Motion Sickness Relief Tablets 8ct
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| MECLIZINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ac6963c4-31c6-325f-ee58-83a0a06597ad | Product name | 5 | 20221206 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11673-356-08 | Motion Sickness Relief | 1 in 1 CARTON | TABLET | 1 | 2 | |
| 11673-356-08 | Motion Sickness Relief | 8 in 1 BLISTER PACK | TABLET | 8 | 2 |
Products#
Every source-derived product name is available through these pages.
- Motion Sickness Relief
- Meclizine Hydrochloride
- SILICON DIOXIDE
- MAGNESIUM STEARATE
- MECLIZINE
- D&C YELLOW NO. 10 ALUMINUM LAKE
- MICROCRYSTALLINE CELLULOSE
- ANHYDROUS LACTOSE
- STARCH, CORN
- SODIUM STARCH GLYCOLATE TYPE A
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 11673-356 | 11673-356-08 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
| D&C YELLOW NO. 10 ALUMINUM LAKE | CQ3XH3DET6 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| ANHYDROUS LACTOSE | 3SY5LH9PMK | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| SODIUM STARCH GLYCOLATE TYPE A | H8AV0SQX4D | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Motion Sickness Relief | MECLIZINE HYDROCHLORIDE | TARGET CORPORATION | 36ba2950-4a09-e5de-e063-6394a90a1771 | 2025-09-04 | Warnings | 11673-356-08 11673-356 11673035608 3df6ca6b-8de9-4c46-e063-6294a90ab4e9 36ba2950-4a09-e5de-e063-6394a90a1771 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
